School of Medicine Publications and Presentations
Diet-enhanced LRG1 expression promotes insulin hypersecretion and ER stress in pancreatic beta cells
Document Type
Article
Publication Date
3-2025
Abstract
Aims/hypothesis: Upregulation of serum leucine-rich α-2-glycoprotein 1 (LRG1) has been implicated in diet-induced obesity and metabolic disorders. However, its specific hormonal actions remain unclear. This study aimed to determine whether diet-enhanced serum LRG1 levels promote hyperinsulinaemia by directly stimulating insulin secretion from pancreatic beta cells.
Methods: Human serum samples were obtained from individuals (both male and female) undergoing plastic surgery. Male C57BL/6 wild-type and Lrg1 whole-body knockout (Lrg1KO) mice were fed a 45% high-fat diet, with serum samples collected every 2 weeks to monitor LRG1 and insulin levels throughout diet-induced obesity. MIN6 beta cells were used to investigate the effects of LRG1 on insulin secretion and intracellular Ca2+ release. Antibodies targeting various LRG1 epitopes were used to neutralise LRG1 stimulation in MIN6 cells, and their effectiveness was tested in vivo to assess their ability to prevent LRG1-induced hyperinsulinaemia.
Results: We observed a significant positive association between human serum LRG1 levels and both age and BMI, with elevated levels observed in individuals with vs without type 2 diabetes. In mice fed a high-fat diet, LRG1 upregulation in serum was associated with hyperinsulinaemia. Lrg1 knockout protected mice from diet-induced islet hyperplasia and the loss of beta cell mass. Furthermore, neutralising LRG1 activity prevented the onset of diet-induced hyperinsulinaemia and preserved glucose tolerance. Mechanistically, LRG1 induces inositol triphosphate (IP3) production and intracellular Ca2+ release from the endoplasmic reticulum (ER) in a phospholipase C (PLC)-dependent manner, leading to excessive insulin secretion and ER stress in MIN6 beta cells.
Conclusions/interpretation: In summary, this study identifies LRG1 as a significant contributor to hyperinsulinaemia and beta cell dysfunction. Targeting LRG1 activity emerges as a promising therapeutic approach for addressing diet-induced beta cell dysfunction and managing type 2 diabetes.
Recommended Citation
Morales, D. D., Ryu, J., Wei, C., Hadley, J. T., Smith, M. R., Bai, J., ... & Dong, L. Q. (2025). Diet-enhanced LRG1 expression promotes insulin hypersecretion and ER stress in pancreatic beta cells. Diabetologia, 68(3), 615-628. https://doi.org/10.1007/s00125-024-06331-0
Publication Title
Diabetologia
DOI
10.1007/s00125-024-06331-0
Academic Level
faculty
Mentor/PI Department
Population Health and Biostatistics

Comments
Reprints and permissions
https://rdcu.be/d2yGJ